All episodes
Managing Stress in AYA Cancer Patients
Prevention of Cisplatin-induced Hearing Loss: Implications for Young People Treated for Osteosarcoma
TACOS: A Phase 2 Trial of Atezolizumab and Cabozantinib in OsteoSarcoma
osTEAo: Making friends after a cancer diagnosis
Interventions to promote physical function during and after treatment for osteosarcoma
The Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan (CAUSAL) study
Developing a Multiscale Transcriptional Atlas of Sarcoma
Immunological Mechanisms of Cancer Defense
osTEAo: Long Term Osteosarcoma Survivors: Where They Were and Where They Are Now
Cabozantinib as a Maintenance Therapy to Prevent Recurrence of High-Risk Pediatric Solid Tumors
osTEAo - Coping with Cancer through Music
OsteoBites Preguntas & Respuestas con Nino Rainusso, MD
TCF-001 TRACK (Target Rare Cancer Knowledge): A Clinical Trial Studying Precision Medicine in Rare Cancers
Repurposing Disulfiram to Overcome Chemotherapy Resistance in Relapsed Sarcomas
osTEAo Tea Spill: AYA Cancer Gab Sesh
Addressing the Unmet Scientific Challenges in Osteosarcoma Treatment through Innovative Engineering Techniques
Implementing Multi-Targeted Tyrosine Kinase Inhibitors in Combination with Chemotherapy for Osteosarcoma
Immune Therapies in EGFR-Expressing Cancers
OsTEAo - An Honest Q&A with Osteosarcoma AYA Patients, Survivors, and Siblings
Treatment of Osteosarcoma Using Smart Targeted Drug Delivery Nanoplatforms
MIB Agents and SARC: A Case Study in Collaboration
OSI Funded Work
OsTEAo - Survivor's Guilt and Grief with grief coach Lori Krause
Pretargeted Approach to Delivery of Radiopharmaceutical Therapy for Bone Cancer - a Click Chemistry Study in Canines with Osteosarcoma
osTEAo - Coping with Humor: A Review of Cancer Memes
The Importance of Patient-Powered Osteosarcoma Research: Count Me In
Osteosarcoma Organoid Models: The Potential and Limitations of Personalized Avatars
Reprogramming NK Cells Within the Tumor Microenvironment of Osteosarcoma Lung Metastases
osTEAo- Returning to Yourself: Confidence and Identity as an AYA Cancer Patient
OSI Connect: Osteosarcoma Answers and Assistance
Open Clinical Trial: GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
SCF-Skp2 Protein Complex as a Therapy for Osteosarcoma by Blocking the Mutational Effects of Rb and p53
osTEAo - Navigating Scanxiety
Cold Atmospheric Plasma: A New Therapeutical Option for Osteosarcoma?
UHRF1 Overexpression Promotes Osteosarcoma Metastasis through Altered Exosome Production and AMPK/SEMA3E Suppression
Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiosurgery (SRS) for Sarcoma
osTEAo - Navigating Campus: Limb-Salvage and Amputation Patient Perspectives
Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks
SarcoSIGHT- A Randomised Controlled Trial of Fluorescence Guided Sarcoma Surgery versus Standard Care
Virtual Surgical Planning and 3D Printing in Pediatric Musculoskeletal Oncological Resections
Two Epigenetically Distinct Cellular States in Osteo are Regulated by a State-Specific Set of Transcription Factors Driving Differential Drug Response
Clinical Trial: Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors
Cell Based Therapies for Osteosarcoma
osTEAo Q&A with Dr. Kurt Weiss - What questions do you have about Osteosarcoma but are afraid to ask?
Interventional Radiology/HIFU Perspectives for Osteosarcoma
Focal Adhesion Kinase (FAK) Inhibition to Improve Losartan-Sunitinib Immunotherapy in Metastatic Osteosarcoma
Updates from Clinical Sequencing of 2,138 Bone and Soft Tissue Sarcomas
osTEAo Presents Halloween Spooky Stories
How Osteosarcoma Evolves from Diagnosis to Relapse
Transforming the Way Researchers Share Data: Lessons from the Pediatric Cancer Data Commons
osTEAo - Dating & Intimacy with Lauren Broschak, MSW, LCSW, OSW-C
Overcoming PD-1 Inhibitor Resistance with a Monoclonal Antibody to Secreted Frizzled-Related Protein 2 in Metastatic Osteosarcoma
Report on the Phase I/II Study of Single-Agent Lenvatinib in Children and Adolescents with Refractory or Relapsed Solid Malignancies and Young Adults with Osteosarcoma
Inhaled Recombinant Human IL-15 in Dogs with Naturally Occurring Pulmonary Metastases from Osteosarcoma or Melanoma: a Phase 1 Study
Outsmarting OS 2021 Funded Research Update: Exploring Aldehyde Dehydrogenase and Androgen Receptor Actions to OutSmart Osteosarcoma Metastases
Back to School: OsteoWarrior and OsteoSibling Perspectives
Combination Therapies to Improve Immune-Mediated Approaches for Osteosarcoma
Using RNA-Nanoparticle Vaccines to Overcome the Immunosuppressive Tumor Microenvironment of Canine Osteosarcoma
COG Project: Every Child - Episode Sponsored by Osteosarcoma Institute
Body Image for AYAs with Cancer with Dr. Lori Weiner
Unanswered Clinical Questions in Sarcoma: Opportunities to Move from Bedside to Bench - Episode Sponsored by Osteosarcoma Institute
Molecular Profiling Identifies Targeted Therapy Opportunities in Pediatric Solid Cancer - Episode Sponsored by Osteosarcoma Institute
Navigating Pediatric Cancer Clinical Trials
Update on OSI funded phase 2 Trial of Olaparib + Ceralasertib in Recurrent Osteosarcoma
Limb Salvage Surgery for OS: Patient & Surgeon Perspectives sponsored by the Osteosarcoma Institute
"Armored" CAR T cells for Osteosarcoma sponsored by BTG Specialty Pharmaceuticals
Immunotherapy for Osteosarcoma - Where Do We Go From Here? Sponsored by BTG Specialty Pharmaceuticals
The Osteosarcoma Project sponsored by BTG Specialty Pharmaceuticals
osTEAo Debut
Update on Clinical Trial Development Targeting Tumor Microenvironment in Refractory and Metastatic Osteosarcoma
Exploring the Use of a Predictive Tool for Methotrexate Clearance sponsored by BTG Specialty Pharmaceuticals
A Phase 1/2 Study of ZN-c3 Plus Gemcitabine in Relapsed or Refractory Osteosarcoma
MYC Amplification as a Prognostic Biomarker in Osteosarcoma Sponsored by BTG Speciality Pharmaceuticals
Compassionate Use of Investigational Drugs: A Strategy to Access Unapproved Therapies for Pediatric Oncology Patients Presented by BTG Speciality Pharmaceuticals
The Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) International Randomized Controlled Trial Sponsored by BTG Specialty Pharmaceuticals
Osteosarcoma Q&A with OsteoWarriors sponsored by BTG Specialty Pharmaceuticals
Truths & Myths of Nutrition in Cancer sponsored by BTG Specialty Pharmaceuticals
Amputation for OS; Patient & Surgeon Perspectives sponsored by BTG Speciality Pharmaceuticals
Surgical Management of Pulmonary Metastases in People with Osteosarcoma - COG Trial
Human Trial for OST-HER2
Osteosarcoma Q&A with Dr. Peter Anderson and OsteoWarriors
Osteobites: Back to Activity, Rotationplasty
OsteoBites: Clinical Trials for Relapsed or Refractory Osteosarcoma - The OLIE Study and Beyond!
Encore, Testing & Research Directory
Real Talk: What it's really like and how WE feel about Osteosarcoma.
Planning for Dignity and What Matters Most to You
Let's Talk Fertility and Osteosarcoma
How "Hydroxychloroquine and "self-eating" works with Osteosarcoma.
Osteosarcoma Update from Dr. Huang - 2019 OutSmarting Osteosarcoma recipient
OsteoBites Welcomes Junior Board Members to discuss "Four OsteoWarriors' Perspectives".
OsteoBites welcomes Dr. Moyez Jiwa to discuss "The Art of Doctoring"
Osteosarcoma OsteoBites S2 Ep 18: Richard Gorlick, MD & Yifei Wang, MD “Antibody Drug Conjugates for Osteosarcoma”
Osteosarcoma OsteoBites S2 Ep 17: Lara Davis, MD, OHSU Knight Cancer Institute “New Osteosarcoma Clinical Trials”
Osteosarcoma OsteoBites S2 Ep 16: Julie Lanford, MPH, RD, CSO, LDN on “Nutrition & Cancer; Truths & Myths”
Osteosarcoma OsteoBites S2 Ep 15: Katie Greenzang, MD, EdM Dana-Farber CI & Harvard Med School “What’s Next? Survivorship"
Osteosarcoma OsteoBites S2 Ep 14: Lillian Guenther, MD Dana-Farber CI & Harvard Med School “CRISPR Screening to Identify Novel Genomic Targets"
Osteosarcoma OsteoBites S2 E13: Scott Sauer, PhD on “Preventing Osteosarcoma Lethal Recurrence by Targeting Disseminated Tumor Cells”
Osteosarcoma OsteoBites S2 Ep12: Dan Prince, MD, MPH on “Regenerative Surgery for Bone Sarcomas”
Osteosarcoma OsteoBites S2 Ep 11: Ines Lohse, PhD on “Drug Sensitivity Testing for the Treatment Stratification of Cancer Patients”
Osteosarcoma OsteoBites S2 Ep 10: Sumit Gupta, MD, PhD, FRCPC “Long Term Mental Health Outcomes in Adolescents and Young Adults with Cancer”